Research Alliance Corp III has received a recent update regarding its ownership from Bank of America Corp. This filing indicates a minor adjustment in the number of shares held by Bank of America, which may influence the company's positioning in the competitive pharmaceutical preparations sector.

Research Alliance Corp III operates under the Standard Industrial Classification (SIC) code 2834, which pertains to pharmaceutical preparations. The company is listed on the Nasdaq under the ticker RACC. It is categorized as a smaller reporting company and an emerging growth company, as indicated in its filings.

The recent Schedule 13G/A filing, dated October 28, 2026, reveals that Bank of America holds 1,189 shares of Class A Ordinary Shares in Research Alliance Corp III. This represents a negligible ownership percentage of 0.0% of the total outstanding shares, which were reported as 7,775,000 in the company's Form 10-Q filed on August 12, 2026. The filing states, "The beneficial ownership calculation relies on the 7,775,000 outstanding shares disclosed in the Form 10-Q by the issuer on August 12, 2026, which reports share totals as of August 10, 2026."

This update may affect various stakeholders, including investors and analysts monitoring the pharmaceutical preparations sector. The filing also indicates that the shares were acquired and are held in the ordinary course of business, without the intention of influencing control over Research Alliance Corp III.

As for what’s next, the filing does not specify any upcoming actions or events related to this change in ownership.